(40)Applications for the respective renewals of the approval of the active substances amisulbrom, Bacillus amyloliquefaciens strain MBI 600, cyantraniliprole, isofetamid and S-abscisic acid were submitted and are being evaluated in accordance with Commission Implementing Regulation (EU) 2020/1740note.
Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.